Company Encyclopedia
View More
name
iShares ESG Screened S&P Mid-Cap ETF
XJH.US
News
View More

Perpetual Ltd Lowers Stock Position in Ciena Corporation $CIEN

Perpetual Ltd reduced its holdings in Ciena Corporation by 38.1% in the third quarter, now owning 154,875 shares valued at $22,561,000. This move is part of broader institutional adjustments in Ciena's stock. Ciena's stock opened at $230.42, with a market cap of $32.45 billion. Recent earnings exceeded expectations, with a 20.1% revenue increase year-over-year. Insider transactions include significant stock sales by directors. Analysts have set new price targets for Ciena, reflecting its performance and market conditions.

Market Beat·
US
CIEN
+9.32%
Market Beat·
US
CIEN
+9.32%

Did Analyst Upgrade and Margin Strength Just Shift Curtiss-Wright's (CW) Investment Narrative?

Curtiss-Wright has received a favorable analyst upgrade to Zacks Rank #2 (Buy), reflecting increased confidence in its earnings outlook and business quality. The company has shown two years of revenue growth outpacing its sector and a 16.5% operating margin. The upgrade ties stronger analyst sentiment to Curtiss-Wright’s earnings outlook, despite risks related to large defense and nuclear contracts. The company's narrative projects $4.0 billion revenue and $593.3 million earnings by 2028, requiring 6.8% yearly revenue growth.

Simplywall·
US
CW
+2.30%
Simplywall·
US
CW
+2.30%

If You Invested $100 In Ciena Stock 15 Years Ago, You Would Have This Much Today

Ciena (NYSE:CIEN) has delivered an average annual return of 17.33% over the past 15 years, outperforming the market by 5.41% annually. A $100 investment in Ciena 15 years ago would now be worth $1,098.95, highlighting the power of compounded returns. Ciena's current market cap is $32.44 billion.

benzinga_article·
US
CIEN
+9.32%
benzinga_article·
US
CIEN
+9.32%

Chmn Rothblatt Files To Sell 2,000 Of United Therapeutics Corp [UTHR]

Martine A. Rothblatt, Chairman of United Therapeutics Corp, filed a Form 144 with the SEC to sell 2,000 shares on December 19, 2025, through TD Securities. This sale is part of a prearranged trading plan (10b5-1). Filing Form 144 is required before selling restricted stock, allowing the sale within 90 days of filing.

Reuters·
US
UTHR
+2.00%
Reuters·
US
UTHR
+2.00%

Illumina Inc. Stock Outperforms Competitors On Strong Trading Day

Illumina Inc. (ILMN) shares rose 3.27% to $134.78 on Friday, outperforming competitors in a strong trading session. The S&P 500 Index increased by 0.88% and the Dow Jones Industrial Average by 0.38%. This marks the second consecutive day of gains for Illumina, closing 11.94% below its 52-week high. Trading volume was significantly higher than the 50-day average.

Dow Jones·
US
ILMN
+3.27%
Dow Jones·
US
ILMN
+3.27%
© 2025 Longbridge｜Disclaimer